This was the stock's fifth consecutive day of losses.

The S&P 500 slipped 0.4% on Thursday, July 31, 2025, as investors reacted to higher-than-expected inflation data while ...

West Pharmaceutical Services delivered a quarter that outperformed Wall Street’s expectations, reflecting renewed strength in ...

West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Q2 2025 Earnings Call Transcript July 24, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS ...

West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

If you currently own WST and purchased prior to February 16, 2023 please contact Justin Kuehn, Esq. here , by email at ... or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its ...

Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

Shares of West Pharmaceutical Services Inc. slipped 5.59% to $263.51 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.40% to 6,388 ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

President Donald Trump gestures on the day he signs an executive order on prescription drug pricing during a press conference ...